| 12/06/25 | GSK | 11:00:00 | 12 Jun 2025 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 25/05/22 | GSK | 15:41:00 | 25 May 2022 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 01/12/21 | GSK | 11:05:00 | 1 Dec 2021 | | GSK | Total Voting Rights | GSK plc | PRN |
| 01/09/20 | | 15:23:19 | 1 Sept 2020 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 13/08/20 | | 10:48:56 | 13 Aug 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 06/08/20 | | 07:00:01 | 6 Aug 2020 | | | US FDA approves GSK’s BLENREP for multiple myeloma | GlaxoSmithKline PLC | RNS |
| 03/08/20 | | 11:31:22 | 3 Aug 2020 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 03/08/20 | | 07:00:06 | 3 Aug 2020 | | | Sanofi/GSK to supply EU with 300m COVID 19 doses | GlaxoSmithKline PLC | RNS |
| 31/07/20 | | 12:00:06 | 31 Jul 2020 | | | Sanofi & GSK picked for Op. Warp Speed by US Gov. | GlaxoSmithKline PLC | RNS |
| 29/07/20 | | 14:02:43 | 29 Jul 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 29/07/20 | | 12:00:07 | 29 Jul 2020 | | | 2nd Quarter Results | GlaxoSmithKline PLC | RNS |
| 29/07/20 | | 07:00:10 | 29 Jul 2020 | | | Sanofi and GSK agree UK doses of COVID-19 vaccine | GlaxoSmithKline PLC | RNS |
| 28/07/20 | | 15:23:08 | 28 Jul 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 24/07/20 | | 13:16:55 | 24 Jul 2020 | | | GSK receives positive CHMP opinion for Belamaf | GlaxoSmithKline PLC | RNS |
| 20/07/20 | | 07:00:06 | 20 Jul 2020 | | | GSK and CureVac enter collaboration | GlaxoSmithKline PLC | RNS |
| 15/07/20 | | 09:31:43 | 15 Jul 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 15/07/20 | | 07:00:06 | 15 Jul 2020 | | | FDA Panel Votes IN FAVOR of Belantamab mafodotin | GlaxoSmithKline PLC | RNS |
| 14/07/20 | | 13:19:48 | 14 Jul 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 13/07/20 | | 17:42:55 | 13 Jul 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/07/20 | | 16:41:51 | 10 Jul 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/07/20 | | 15:15:26 | 10 Jul 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/07/20 | | 15:07:48 | 10 Jul 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/07/20 | | 12:25:51 | 1 Jul 2020 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 29/06/20 | | 08:00:02 | 29 Jun 2020 | | | GSK’s daprodustat gains first regulatory approval | GlaxoSmithKline PLC | RNS |
| 19/06/20 | | 15:22:25 | 19 Jun 2020 | | | FDA Advisory Committee review belantamab mafodotin | GlaxoSmithKline PLC | RNS |
| 18/06/20 | | 12:25:00 | 18 Jun 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/06/20 | | 12:51:02 | 16 Jun 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/06/20 | | 15:56:43 | 11 Jun 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 09/06/20 | | 14:16:15 | 9 Jun 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/06/20 | | 12:14:40 | 1 Jun 2020 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 29/05/20 | | 16:41:52 | 29 May 2020 | | | Second Price Monitoring Extn | GlaxoSmithKline PLC | RNS |
| 29/05/20 | | 16:37:03 | 29 May 2020 | | | Price Monitoring Extension | GlaxoSmithKline PLC | RNS |
| 26/05/20 | | 11:53:02 | 26 May 2020 | | | Block listing Interim Review | GlaxoSmithKline PLC | RNS |
| 19/05/20 | | 17:51:01 | 19 May 2020 | | | Holding(s) in Company | GlaxoSmithKline PLC | RNS |
| 18/05/20 | | 07:09:30 | 18 May 2020 | | | ViiV PrEP jab shows high efficacy over daily pill | GlaxoSmithKline PLC | RNS |
| 13/05/20 | | 17:04:42 | 13 May 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/05/20 | | 18:07:47 | 11 May 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 07/05/20 | | 15:52:18 | 7 May 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 07/05/20 | | 07:56:27 | 7 May 2020 | | | GSK sells its holding in Hindustan Unilever | GlaxoSmithKline PLC | RNS |
| 06/05/20 | | 17:40:46 | 6 May 2020 | | | Result of AGM | GlaxoSmithKline PLC | RNS |
| 04/05/20 | | 18:00:30 | 4 May 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 04/05/20 | | 17:40:33 | 4 May 2020 | | | Publication of a Prospectus | GlaxoSmithKline PLC | RNS |
| 04/05/20 | | 16:18:03 | 4 May 2020 | | | Rights attached to ordinary shares | GlaxoSmithKline PLC | RNS |
| 01/05/20 | | 15:45:01 | 1 May 2020 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 30/04/20 | | 07:00:05 | 30 Apr 2020 | | | GSK’s Zejula approved in first-line ovarian cancer | GlaxoSmithKline PLC | RNS |
| 29/04/20 | | 12:00:07 | 29 Apr 2020 | | | 1st Quarter Results | GlaxoSmithKline PLC | RNS |
| 29/04/20 | | 11:00:27 | 29 Apr 2020 | | | Arrangements for Shareholder Webcast | GlaxoSmithKline PLC | RNS |
| 16/04/20 | | 15:25:06 | 16 Apr 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/04/20 | | 14:21:06 | 16 Apr 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 16/04/20 | | 13:49:20 | 16 Apr 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |